Global Cellular Health Screening Market Likely to Grow at a Steady Pace through 2022


Published on : Nov 13, 2017

Albany, New York, November 13, 2017: The global cellular health screening market continues to grow at a steady pace owing to a number of factors. Globally, focus on preventive healthcare is rising, which has increased the scope of cellular health screening market. Also, increase in geriatric population in advanced markets is contributing to the growth of the market. These factors are likely to push market growth during the forecast period 2017-2022 according to a new research report added to the repository of Market Research Hub (MRH). The report is titled “Cellular Health Screening Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2022”.

The report offers detailed segmentation on various parameters to give readers holistic insights on the growth of this market. According to the report, the global market is likely to surpass US$ 3 billion by the end of forecast period. By test type, the report has segmented the market into mult0-test panels, oxidative stress tests, inflammation tests, telomere tests, and heavy metal tests. Among these, demand for telomere tests is likely to remain the highest during the forecast period. Telomere tests account for nearly one-third of global revenues in 2017, and this segment is likely to surge at over 8% CAGR during the forecast period.

Demand for telomere tests is likely to be driven by focus on preventive healthcare in both developing and developed countries. Governments across the world are trying to improve the quality of screening tests, and are investing in latest R&D procedures. As telomere tests are crucial diagnostic tests that help in understanding how aging is affecting the body of an individual, these tests are likely to gain prominence during the forecast period.

According to the report, North America is one of the leading markets for cellular healthcare screening, and adoption is Europe is also growing at a brisk pace. These regions are likely to remain at the forefront of global adoption during the forecast period. The cellular healthcare screening market in North America is likely to grow at a CAGR of over 8% to rake in over US$ 1.3 billion by the end of forecast period. Europe, another significant market globally, is projected to grow at over 7% CAGR during the forecast period. Asia Pacific except Japan (APEJ), one of the leading markets for cellular healthcare market, is likely to offer opportunities to global players during the forecast period.

The leading players in the cellular health screening market include Life Length S.L., Quest Diagnostics Incorporated, Cell Science Systems Corporation, Bio-Reference Laboratories Inc., Genova Diagnostics Inc., Laboratory Corporation of America Holdings, Cleveland HeartLab Inc., and SpectraCell Laboratories Inc.

Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1363986

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top